The relationship between fatigue and light exposure during chemotherapy.
Journal: 2006/February - Supportive Care in Cancer
ISSN: 0941-4355
Abstract:
BACKGROUND
Fatigue is one of the most common and distressing complaints among cancer patients, not only during radiation and chemotherapy, but also for months to years after the completion of treatment. Fatigue interferes with patients' daily lives, reduces their quality of life, and is often a significant reason why patients discontinue treatment. We hypothesized that some of the fatigue may be related to disrupted circadian rhythms and low light exposure. The main objective of this study therefore was to investigate the association between fatigue and light exposure among patients with breast cancer.
METHODS
As part of a larger, ongoing prospective study on fatigue, sleep, and circadian rhythms in patients with breast cancer, an analysis of 63 women newly diagnosed with stage I-IIIA breast cancer and scheduled to receive four cycles of adjuvant or neoadjuvant anthracycline-based chemotherapy was conducted. Data were collected before and during weeks 1, 2, and 3 of cycle 1 and cycle 4. Fatigue was assessed using the Short Form of Multidimensional Fatigue Symptom Inventory. Light exposure was recorded with a wrist actigraph.
RESULTS
There were significant correlations between fatigue levels and light exposure (r=-0.28 to -0.45) within both cycle 1 and cycle 4, such that higher levels of fatigue were associated with less light exposure. There were also significant correlations between changes in light exposure and changes in fatigue within the first 2 weeks of each cycle (r=-0.28 to -0.52).
CONCLUSIONS
Increased fatigue was significantly correlated with decreased light exposure among patients with breast cancer. Although the cause and effect of exacerbated fatigue and decreased light exposure cannot be confirmed by the current study, and lower light exposure may just in part be due to the fatigued patients spending less time outdoors in bright light, two hypotheses are proposed about the mechanisms by which light may alleviate the fatigue of patients with breast cancer. These results suggest the need for prospective intervention studies of light therapy for breast-cancer-related fatigue.
Relations:
Content
Citations
(20)
References
(32)
Diseases
(1)
Conditions
(1)
Organisms
(1)
Processes
(1)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
Support Care Cancer 13(12): 1010-1017

The relationship between fatigue and light exposure during chemotherapy

Department of Psychiatry, University of California San Diego, San Diego, CA, USA
Veterans Affairs San Diego Healthcare System, San Diego, CA, USA
UCSD Rebecca and John Moores Cancer Center, San Diego, CA, USA
Department of Medicine, University of California at San Diego, San Diego, CA, USA
Yakima Regional Cancer Care Center, Yakima, WA, USA
San Diego State University/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA
Department of Surgery, University of California at San Diego, San Diego, CA, USA
Department of Psychiatry 116A, VASDHS, 3350 La Jolla Village Drive, San Diego, CA 92161, USA
e-mail: ude.dscu@learsiilocnas, Tel.: +1-858-6423828, Fax: +1-858-5527536

Abstract

Background

Fatigue is one of the most common and distressing complaints among cancer patients, not only during radiation and chemotherapy, but also for months to years after the completion of treatment. Fatigue interferes with patients’ daily lives, reduces their quality of life, and is often a significant reason why patients discontinue treatment. We hypothesized that some of the fatigue may be related to disrupted circadian rhythms and low light exposure. The main objective of this study therefore was to investigate the association between fatigue and light exposure among patients with breast cancer.

Methods

As part of a larger, ongoing prospective study on fatigue, sleep, and circadian rhythms in patients with breast cancer, an analysis of 63 women newly diagnosed with stage I–IIIA breast cancer and scheduled to receive four cycles of adjuvant or neoadjuvant anthracycline-based chemotherapy was conducted. Data were collected before and during weeks 1, 2, and 3 of cycle 1 and cycle 4. Fatigue was assessed using the Short Form of Multidimensional Fatigue Symptom Inventory. Light exposure was recorded with a wrist actigraph.

Results

There were significant correlations between fatigue levels and light exposure (r=−0.28 to −0.45) within both cycle 1 and cycle 4, such that higher levels of fatigue were associated with less light exposure. There were also significant correlations between changes in light exposure and changes in fatigue within the first 2 weeks of each cycle (r=−0.28 to −0.52).

Conclusions

Increased fatigue was significantly correlated with decreased light exposure among patients with breast cancer. Although the cause and effect of exacerbated fatigue and decreased light exposure cannot be confirmed by the current study, and lower light exposure may just in part be due to the fatigued patients spending less time outdoors in bright light, two hypotheses are proposed about the mechanisms by which light may alleviate the fatigue of patients with breast cancer. These results suggest the need for prospective intervention studies of light therapy for breast-cancer-related fatigue.

Keywords: Breast cancer, Fatigue, Light, Chemotherapy
Abstract

References

  • 1. Winningham ML, Nail LM, Burke MB, Brophy L, Cimprich B, Jones LS, Pickard-Holley S, Rhodes V, Pierre B, St, Beck S, Glass EC, Mock VL, Mooney KH, Piper BFatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum. 1994;21:23–36.[PubMed][Google Scholar]
  • 2. Morrow GR, Andrews PLR, Hickok JT, Roscoe JA, Matteson SFatigue associated with cancer and its treatment. Support Care Cancer. 2002;10:389–398.[PubMed][Google Scholar]
  • 3. Smets EMA, Garssen B, Schuster-Uitterhoeve AL, de Haes JCFatigue in cancer patients. Br J Cancer. 1993;68:220–224.[Google Scholar]
  • 4. Richardson AFatigue in cancer patients: a review of the literature. Eur J Cancer Care. 1995;4:20–32.[PubMed][Google Scholar]
  • 5. de Jong N, Courtens AM, Abu-Saad HH, Schouten HCFatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature. Cancer Nurs. 2002;25:283–297.[PubMed][Google Scholar]
  • 6. Lindley C, Vasa S, Sawyer WT, Winer EPQuality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol. 1998;16:1380–1387.[PubMed][Google Scholar]
  • 7. Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TRFatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000;18:743–753.[PubMed][Google Scholar]
  • 8. Ancoli-Israel S, Parker BA, Marler M, Sadler GR, Jones V, Liu LFatigue, sleep and circadian rhythms prior to chemotherapy in breast cancer. Breast Cancer Res Treat. 2004;8(Suppl 1) abstract. [PubMed][Google Scholar]
  • 9. Jacobsen PB, Hann DM, Azzarello LM, Horton J, Balducci L, Lyman GHFatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage. 1999;18:233–242.[PubMed][Google Scholar]
  • 10. Cimprich BPretreatment symptom distress in women newly diagnosed with breast cancer. Cancer Nurs. 1999;22:185–194.[PubMed][Google Scholar]
  • 11. Visser MRM, Smets EMAFatigue, depression and quality of life in cancer patients: how are they related? Support Care Cancer. 1998;6:101–108.[PubMed][Google Scholar]
  • 12. Tchen N, Juffs HG, Downie FP, Yi Q-L, Hu H, Chemerynsky I, Clemons M, Crump M, Goss PE, Warr D, Tweedale ME, Tannock IFCognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol. 2003;21:4175–4183.[PubMed][Google Scholar]
  • 13. Ancoli-Israel S, Moore P, Jones VThe relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care. 2001;10:245–255.[Google Scholar]
  • 14. Jacobsen PB, Stein KIs fatigue a long-term side effect of breast cancer treatment? Cancer Control. 1999;6:256–263.[PubMed][Google Scholar]
  • 15. Remick RADiagnosis and management of depression in primary care: a clinical update and review. CMAJ. 2002;167:1253–1260.[Google Scholar]
  • 16. Prasko J, Horacek J, Klaschka J, Kosova J, Ondrackova I, Sipek JBright light therapy and/or imipramine for inpatients with recurrent non-seasonal depression. Neuroendocrinol Lett. 2002;23:109–113.[PubMed][Google Scholar]
  • 17. Kripke DFLight treatment for nonseasonal depression: speed, efficacy, and combined treatment. J Affect Disord. 1998;49:109–117.[PubMed][Google Scholar]
  • 18. Dijk DJ, Boulos Z, Eastman CI, Lewy AJ, Campbell SS, Terman M. Light treatment for sleep disorders: consensus report. II. Basic properties of circadian physiology and sleep regulation. J Biol Rhythms. 1995;10:113–125.[PubMed]
  • 19. Terman M, Lewy AJ, Dijk DJ, Boulos Z, Eastman CI, Campbell SS. Light treatment for sleep disorders: consensus report. IV. Sleep phase and duration disturbances. J Biol Rhythms. 1995;10:135–147.[PubMed]
  • 20. Eastman CI, Boulos Z, Terman M, Campbell SS, Dijk DJ, Lewy AJ. Light treatment for sleep disorders: consensus report. VI. Shift work. J Biol Rhythms. 1995;10:157–164.[PubMed]
  • 21. Boulos Z, Campbell SS, Lewy AJ, Terman M, Dijk DJ, Eastman CI. Light treatment for sleep disorders: consensus report. VII. Jet lag. J Biol Rhythms. 1995;10:167–176.[PubMed]
  • 22. Stein KD, Martin SC, Hann DM, Jacobsen PBA multidimensional measure of fatigue for use with cancer patients. Cancer Pract. 1998;6:143–152.[PubMed][Google Scholar]
  • 23. Stein KD, Jacobsen PB, Blanchard CM, Thors CFurther validation of the multidimensional fatigue symptom inventory—short form. J Pain Symptom Manage. 2004;27:14–23.[Google Scholar]
  • 24. Ancoli-Israel S, Cole R, Alessi CA, Chambers M, Moorcroft WH, Pollak CThe role of actigraphy in the study of sleep and circadian rhythms. Sleep. 2003;26:342–392.[PubMed][Google Scholar]
  • 25. Cole RJ, Kripke DF, Gruen W, Nava JAmbulatory monitoring of light exposure: comparison of measurements at forehead and wrist. Sleep Res. 1990;19:364.[PubMed][Google Scholar]
  • 26. SAS Institute Inc (1999) SAS/STAT user’s guide, version 81–3884
  • 27. Berger AMPatterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol Nurs Forum. 1998;25:51–62.[PubMed][Google Scholar]
  • 28. Schwartz ALDaily fatigue patterns and effect of exercise in women with breast cancer. Cancer Pract. 2000;8:16–24.[PubMed][Google Scholar]
  • 29. Küller RThe influence of light on circarhythms in humans. J Physiol Anthropol Appl Hum Sci. 2002;21:87–91.[PubMed][Google Scholar]
  • 30. Berger AM, Farr LThe influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. Oncol Nurs Forum. 1999;26:1663–1671.[PubMed][Google Scholar]
  • 31. Roscoe JA, Morrow GR, Hickok JT, Bushunow P, Matteson S, Rakita D, Andrews PLRTemporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support Care Cancer. 2002;10:329–336.[PubMed][Google Scholar]
  • 32. Ancoli-Israel S, Martin JL, Kripke DF, Marler M, Klauber MREffect of light treatment on sleep and circadian rhythms in demented nursing home patients. J Am Geriat Soc. 2002;50:282–289.[Google Scholar]
  • 33. Ancoli-Israel S, Gehrman PR, Martin JL, Shochat T, Marler M, Corey-Bloom J, Levi LIncreased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer’s disease patients. Behav Sleep Med. 2003;1:22–36.[PubMed][Google Scholar]
  • 34. Magnusson A, Boivin DSeasonal affective disorder: an overview. Chronobiol Int. 2003;20:189–207.[PubMed][Google Scholar]
  • 35. Zubieta JK, Engleberg NC, Yargic LI, Pande AC, Demitrack MASeasonal symptom variation in patients with chronic fatigue—comparison with major mood disorders. J Psychiatr Res. 1994;28:13–22.[PubMed][Google Scholar]
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.